Results

RDF/XMLNTriplesTurtleShow queryShare ▶
SubjectPredicateObject
http://purl.uniprot.org/citations/34485821http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/34485821http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/34485821http://www.w3.org/2000/01/rdf-schema#comment"

Background

Expressing afucosylated human IgG1 antibodies with Chinese hamster ovary (CHO) cells deficient of α-(1,6)-fucosyltransferase (FUT8) is being more and more accepted as a routine method to enhance antibody-dependent cellular cytotoxicity (ADCC) of therapeutic antibodies, especially for anti-cancer regimens. However, in pre-clinical studies relying on disease models other than mice and primates, e.g., those underrepresented species for infectious diseases, it is less clear whether such afucosylated antibodies can demonstrate enhanced therapeutic index. This is because the orthologues of human FcγRIIIA or mouse FcγRIV from those species have not been well characterized.

Methods

We set up a luciferase-based ADCC assay with Jurkat reporter cells expressing FcγRIIIA/FcγRIV from human, mouse, rat, hamster, guinea pig, ferret, rabbit, cat, dog, pig and monkey, and also produced human, mouse, hamster, rabbit and pig IgG from wild type and Fut8-/- CHO cells or hybridomas.

Results

We confirmed that enhanced stimulation through FcγRIIIA/FcγRIV by afucosylated IgG, as compared with wild type IgG, is a cross-species phenomenon.

Conclusions

Thus, efficacy and toxicology studies of the next generation afucosylated therapeutic IgG and Fc fusion proteins in these underrepresented animal models should be expected to generate translatable data for treating human diseases, leading to the expanded applications of this new class of glycoengineered biologics."xsd:string
http://purl.uniprot.org/citations/34485821http://purl.org/dc/terms/identifier"doi:10.1093/abt/tbab016"xsd:string
http://purl.uniprot.org/citations/34485821http://purl.org/dc/terms/identifier"doi:10.1093/abt/tbab016"xsd:string
http://purl.uniprot.org/citations/34485821http://purl.uniprot.org/core/author"Gao W."xsd:string
http://purl.uniprot.org/citations/34485821http://purl.uniprot.org/core/author"Gao W."xsd:string
http://purl.uniprot.org/citations/34485821http://purl.uniprot.org/core/author"Mao C."xsd:string
http://purl.uniprot.org/citations/34485821http://purl.uniprot.org/core/author"Mao C."xsd:string
http://purl.uniprot.org/citations/34485821http://purl.uniprot.org/core/author"Zhong X."xsd:string
http://purl.uniprot.org/citations/34485821http://purl.uniprot.org/core/author"Zhong X."xsd:string
http://purl.uniprot.org/citations/34485821http://purl.uniprot.org/core/author"Near R."xsd:string
http://purl.uniprot.org/citations/34485821http://purl.uniprot.org/core/author"Near R."xsd:string
http://purl.uniprot.org/citations/34485821http://purl.uniprot.org/core/date"2021"xsd:gYear
http://purl.uniprot.org/citations/34485821http://purl.uniprot.org/core/date"2021"xsd:gYear
http://purl.uniprot.org/citations/34485821http://purl.uniprot.org/core/name"Antib Ther"xsd:string
http://purl.uniprot.org/citations/34485821http://purl.uniprot.org/core/name"Antib Ther"xsd:string
http://purl.uniprot.org/citations/34485821http://purl.uniprot.org/core/pages"159-170"xsd:string
http://purl.uniprot.org/citations/34485821http://purl.uniprot.org/core/pages"159-170"xsd:string
http://purl.uniprot.org/citations/34485821http://purl.uniprot.org/core/title"Cross-species higher sensitivities of FcgammaRIIIA/FcgammaRIV to afucosylated IgG for enhanced ADCC."xsd:string
http://purl.uniprot.org/citations/34485821http://purl.uniprot.org/core/title"Cross-species higher sensitivities of FcgammaRIIIA/FcgammaRIV to afucosylated IgG for enhanced ADCC."xsd:string
http://purl.uniprot.org/citations/34485821http://purl.uniprot.org/core/volume"4"xsd:string
http://purl.uniprot.org/citations/34485821http://purl.uniprot.org/core/volume"4"xsd:string
http://purl.uniprot.org/citations/34485821http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/34485821
http://purl.uniprot.org/citations/34485821http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/34485821
▶